Search Results 151-160 of 24302 for B cell lymphomas
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Overview.
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin. Cancer Epidemiol Biomarkers Prev ...
... B-cell lymphoma 2 (BCL2) ... Collecting Tissue Samples From Patients With ... Cell Non-Hodgkin Lymphomas Scottsdale/Phoenix, AZ; Rochester, MN. This ...
The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer ...
Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx Testing) into the routine work-up of diffuse large B-cell lymphoma ...
Most B-cell lymphomas are caused by changes in transcription factors and chromatin modifier genes. Transcription factors affect genetic information. Dr.
... B-cell Non-Hodgkin Lymphoma (B-NHL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Bone marrow transplant, CAR-T cell therapy, B-cell lymphoma, Waldenstrom macroglobulinemia, Non-Hodgkin lymphoma, Folli...cular lymphoma, Hodgkin lymphoma.
... cell lymphoma, Lymphoma, Small lymphocytic lymp...homa, B-cell lymphoma, Diffuse large b-cell lymphoma, T-cell lymphoma, Follicular lymphoma, Cutaneous b-cell ...
... B-cell lymphomas and leukemias into remission. However, leukemia and lymphoma tumors can change over time and become resistant to therapies, resulting in a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!